Melbourne biosciences company Esfam Biotech says it is on track to commence human trials for a COVID-19 treatment by the end of 2021.
Researchers at Flinders University claim a breakthrough in finding the structure of "rogue clones" that cause the auto-immune disease Lupus and say it could help lead to effective treatments.